Selank + Semax 5/5mg
Two-component research blend (Selank / Semax) at 5/5mg.
Selank + Semax 5/5mg is supplied by Bench Grade Peptides as a lyophilized powder in a sealed, lot-numbered vial, for laboratory research use only — not for human or veterinary use.
Its published Certificate of Analysis (lot 00011/0011, analyzed September 3, 2026) is from AV Analytics, a third-party laboratory, and reports 99.8% purity by HPLC; every published lot is listed on the product's COA page. Vials ship at ambient temperature in protective packaging from Florida (Bench Grade Peptides LLC is registered in Dover, Delaware), with storage notes on the lot's certificate.
Two-component research blend (Selank / Semax) at 5/5mg.
The primary literature on this compound includes Component-level literature; supplied as a pre-mixed research blend. The references below link directly to the published record.
Lots are synthesized in the USA and verified by HPLC; where a lot's Certificate of Analysis is published, it is in the COA library. It is supplied strictly for laboratory research use.
Researchers also ordered
- ARA-290Erythropoietin-derived 11-residue research peptide studied in neuropathy and tissue-protection literature.
- CartalaxSynthetic peptide bioregulator studied in joint and cartilage research models.
- DihexaAngiotensin IV analog studied in synaptogenesis and HGF/c-Met receptor research.
- DSIPDelta-sleep-inducing nonapeptide studied in sleep-architecture research.